Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of radiotherapeutics to treat cancer patients.
Blue Earth Therapeutics has raised $76.5M in total funding. The most recent round was Series A. The last funding was announced in October 2024.
Blue Earth Therapeutics's investors include Sands Capital Ventures, Soleus Capital, Woodline Partners, Bracco, PBM Capital Group.
Blue Earth Therapeutics is headquartered in Oxford, United Kingdom.
Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of radiotherapeutics to treat cancer patients.
Blue Earth Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Blue Earth Therapeutics — Funding & Investors." VCBacked, October 30, 2024, https://www.vcbacked.co/company/blue-earth-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Blue Earth Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/blue-earth-therapeutics
{{cite web |title=Blue Earth Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/blue-earth-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated